Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.80 +0.34 (+7.51%)
At close: Sep 30, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Short term Debt (2020 - 2025)

Updated

Verrica Pharmaceuticals (VRCA) recorded Short term Debt of $12.46 million in Q3 2025, down 1.7% from the prior quarter.

Analysis

Verrica Pharmaceuticals (VRCA) Short term Debt (2020 - 2025) Analysis & Trends

At the end of FY2024, Verrica Pharmaceuticals reported Short term Debt of $12.94 million.

  • Annual Short term Debt has a four-year compound annual growth rate of -22.2% (FY2020 to FY2024).
  • Across earlier years, Short term Debt came in at $35.32 million in FY2020.
  • The Q3 2025 figure is the lowest quarterly Short term Debt in data going back to Q2 2020.
  • Per Business Quant, the preceding three quarters came in at $12.67 million (Q2 2025), $12.82 million (Q1 2025) and $12.94 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Verrica Pharmaceuticals 76.62 Mn -6.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 12.46 Mn
Jun 30, 2025 12.67 Mn
Mar 31, 2025 12.82 Mn
Dec 31, 2024 12.94 Mn
Mar 31, 2021 40.67 Mn
Dec 31, 2020 35.32 Mn
Sep 30, 2020 34.98 Mn
Jun 30, 2020 34.72 Mn
API Access

Verrica Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRCA&period=max&api_key=YOUR_API_KEY